{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:34:58Z","timestamp":1789594498687,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54\u2010DK\u2010083912"],"award-info":[{"award-number":["U54\u2010DK\u2010083912"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007519","name":"Nephcure Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019452","name":"Halpin Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019452","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK118189"],"award-info":[{"award-number":["K23DK118189"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00467-021-05176-8","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T17:04:09Z","timestamp":1637255049000},"page":"1585-1595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Determinants of medication adherence in childhood nephrotic syndrome and associations of adherence with clinical outcomes"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6941-0057","authenticated-orcid":false,"given":"Chia-shi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P","family":"Troost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry A","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisha","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Trachtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarak","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Reidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Kaskel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B","family":"Sethna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M","family":"Dell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Hingorani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin V","family":"Lemley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Jar","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie S","family":"Gipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"5176_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629\u2013639","journal-title":"Lancet"},{"key":"5176_CR2","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Gipson DS, Hodson EM, Kidney Disease: Improving Global Outcomes (2013) Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28:415\u2013426","journal-title":"Pediatr Nephrol"},{"key":"5176_CR3","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.2215\/CJN.00380116","volume":"11","author":"TH Banh","year":"2016","unstructured":"Banh TH, Hussain-Shamsy N, Patel V, Vasilevska-Ristovska J, Borges K, Sibbald C, Lipszyc D, Brooke J, Geary D, Langlois V, Reddon M, Pearl R, Levin L, Piekut M, Licht CP, Radhakrishnan S, Aitken-Menezes K, Harvey E, Hebert D, Piscione TD, Parekh RS (2016) Ethnic differences in incidence and outcomes of childhood nephrotic syndrome. Clin J Am Soc Nephrol 11:1760\u20131768","journal-title":"Clin J Am Soc Nephrol"},{"key":"5176_CR4","doi-asserted-by":"publisher","first-page":"2029583","DOI":"10.1155\/2017\/2029583","volume":"2017","author":"CS Wang","year":"2017","unstructured":"Wang CS, Yan J, Palmer R, Bost J, Wolf MF, Greenbaum LA (2017) Childhood nephrotic syndrome management and outcome: a single center retrospective analysis. Int J Nephrol 2017:2029583","journal-title":"Int J Nephrol"},{"key":"5176_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00467-012-2304-8","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Hodson EM, Gipson DS, Kidney Disease: Improving Global Outcomes (2013) Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol 28:409\u2013414","journal-title":"Pediatr Nephrol"},{"key":"5176_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012143","volume":"8","author":"IF Ashoor","year":"2019","unstructured":"Ashoor IF, Mansfield SA, O'Shaughnessy MM, Parekh RS, Zee J, Vasylyeva TL, Kogon AJ, Sethna CB, Glenn DA, Chishti AS, Weaver DJ, Helmuth ME, Fernandez HE, Rheault MN, CureGN Consortium (2019) Prevalence of cardiovascular disease risk factors in childhood glomerular diseases. J Am Heart Assoc 8:e012143","journal-title":"J Am Heart Assoc"},{"key":"5176_CR7","unstructured":"World Health Organization (2003) Adherence to long-term therapies: evidence for action. Sabat\u00e9 E (ed). https:\/\/apps.who.int\/iris\/handle\/10665\/42682"},{"key":"5176_CR8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1542\/peds.2013-1451","volume":"132","author":"ME McGrady","year":"2013","unstructured":"McGrady ME, Hommel KA (2013) Medication adherence and health care utilization in pediatric chronic illness: a systematic review. Pediatrics 132:730\u2013740","journal-title":"Pediatrics"},{"key":"5176_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/ki.2012.428","volume":"83","author":"CA Gadegbeku","year":"2013","unstructured":"Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PX, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ, Lienczewski CC, Adler SG, Appel GB, Cattran DC, Choi MJ, Contreras G, Dell KM, Fervenza FC, Gibson KL, Greenbaum LA, Hernandez JD, Hewitt SM, Hingorani SR, Hladunewich M, Hogan MC, Hogan SL, Kaskel FJ, Lieske JC, Meyers KE, Nachman PH, Nast CC, Neu AM, Reich HN, Sedor JR, Sethna CB, Trachtman H, Tuttle KR, Zhdanova O, Zilleruelo GE, Kretzler M (2013) Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int 83:749\u2013756","journal-title":"Kidney Int"},{"key":"5176_CR10","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/MLR.0b013e318269e121","volume":"50","author":"CI Voils","year":"2012","unstructured":"Voils CI, Maciejewski ML, Hoyle RH, Reeve BB, Gallagher P, Bryson CL, Yancy WS Jr (2012) Initial validation of a self-report measure of the extent of and reasons for medication nonadherence. Med Care 50:1013\u20131019","journal-title":"Med Care"},{"key":"5176_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/jpepsy\/jsm030","volume":"32","author":"LE Simons","year":"2007","unstructured":"Simons LE, Blount RL (2007) Identifying barriers to medication adherence in adolescent transplant recipients. J Pediatr Psychol 32:831\u2013844","journal-title":"J Pediatr Psychol"},{"key":"5176_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"5176_CR13","unstructured":"United States Renal Data System (2020) USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD https:\/\/adr.usrds.org\/2020"},{"key":"5176_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2215\/CJN.05750513","volume":"9","author":"TD Blydt-Hansen","year":"2014","unstructured":"Blydt-Hansen TD, Pierce CB, Cai Y, Samsonov D, Massengill S, Moxey-Mims M, Warady BA, Furth SL (2014) Medication treatment complexity and adherence in children with CKD. Clin J Am Soc Nephrol 9:247\u2013254","journal-title":"Clin J Am Soc Nephrol"},{"key":"5176_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s11096-020-00975-9","volume":"42","author":"D Yin","year":"2020","unstructured":"Yin D, Guo Q, Geng X, Song Y, Song J, Wang S, Li X, Duan J (2020) The effect of inpatient pharmaceutical care on nephrotic syndrome patients after discharge: a randomized controlled trial. Int J Clin Pharm 42:617\u2013624","journal-title":"Int J Clin Pharm"},{"key":"5176_CR16","doi-asserted-by":"crossref","unstructured":"Hsu C-N, Huang S-H, Tain Y-L(2019) Adherence to long-term use of renin-angiotensin II-aldosterone system inhibitors in children with chronic kidney disease. BMC Pediatr 19:64","DOI":"10.1186\/s12887-019-1434-6"},{"key":"5176_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1399-3046.2010.01299.x","volume":"14","author":"F Dobbels","year":"2010","unstructured":"Dobbels F, Ruppar T, De Geest S, Decorte A, Van Damme-Lombaerts R, Fine RN (2010) Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review. Pediatr Transplant 14:603\u2013613","journal-title":"Pediatr Transplant"},{"key":"5176_CR18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jpeds.2009.04.009","volume":"155","author":"A Tong","year":"2009","unstructured":"Tong A, Morton R, Howard K, Craig JC (2009) Adolescent experiences following organ transplantation: a systematic review of qualitative studies. J Pediatr 155:542\u2013549","journal-title":"J Pediatr"},{"key":"5176_CR19","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1681\/ASN.2017020216","volume":"28","author":"TE Nevins","year":"2017","unstructured":"Nevins TE, Nickerson PW, Dew MA (2017) Understanding medication nonadherence after kidney transplant. J Am Soc Nephrol 28:2290\u20132301","journal-title":"J Am Soc Nephrol"},{"key":"5176_CR20","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00467-004-1791-7","volume":"20","author":"T Ulinski","year":"2005","unstructured":"Ulinski T, Carlier-Legris A, Schlecht D, Ranchin B, Cochat P (2005) Triamcinolone acetonide: a new management of noncompliance in nephrotic children. Pediatr Nephrol 20:759\u2013762","journal-title":"Pediatr Nephrol"},{"key":"5176_CR21","first-page":"217047","volume":"2015","author":"WY Lam","year":"2015","unstructured":"Lam WY, Fresco P (2015) Medication adherence measures: an overview. Biomed Res Int 2015:217047","journal-title":"Biomed Res Int"},{"key":"5176_CR22","doi-asserted-by":"publisher","DOI":"10.2196\/19179","volume":"22","author":"YH Kwan","year":"2020","unstructured":"Kwan YH, Weng SD, Loh DHF, Phang JK, Oo LJY, Blalock DV, Chew EH, Yap KZ, Tan CYK, Yoon S, Fong W, Ostbye T, Low LL, Bosworth HB, Thumboo J (2020) Measurement properties of existing patient-reported outcome measures on medication adherence: systematic review. J Med Internet Res 22:e19179","journal-title":"J Med Internet Res"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05176-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05176-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05176-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T07:13:08Z","timestamp":1655104388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05176-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["5176"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05176-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"12 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board (IRB) approval for this study was obtained via the single IRB of record at the University of Michigan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent for study participation was obtained at NEPTUNE enrollment from the legal guardians of the minor participants. Assent was obtained where applicable according to single and local IRB guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Tarak Srivastava has received research funding from Bristol-Myers-Squibb, Retrophin, Mallinckrodt, and Alexion, and has consulted for Alnylam. Larry A. Greenbaum receives research support from Reata Pharmaceuticals and Vertex. He also serves as a consultant for Travere. Howard Trachtman has consultancy agreements through NYU Grossman School of Medicine with Travere Therapeurtics and Goldfinch Bio. He is a consultant to Otsuka and Chemocentryx as member of study data monitoring committees. Debbie S Gipson receives research support from Goldfinch Bio, Novartis, Travere, and Reata. She is a scientific advisor through the University of Michigan with Vertex and AstraZeneca. Kimberly Reidy is a site investigator for Advicienne- and Travere-sponsored clinical trials. Katherine Dell is a site investigator for Travere and AMGEN- sponsored clinical trials and has a consultancy agreement with Sanofi Genzyme.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest\/Competing interest"}}]}}